Clinical trial
A Randomised Placebo Controlled Trial of Rosuvastatin in Systemic Lupus Erythematosus
NCT01170585 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Placebo Controlled Trial of Rosuvastatin in Systemic Lupus Erythematosus
- Lead sponsor
- Imperial College London
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- June 30, 2014
- Enrollment
- 33 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, systemic lupus erythematosus